Cancer, a disease of aging (part 1) - trends in older adult cancer mortality in Switzerland 1991-2008 by Schmidlin, Kurt et al.
Original article | Published 14 August 2012, doi:10.4414/smw.2012.13637
Cite this as: Swiss Med Wkly. 2012;142:w13637
Cancer, a disease of aging – part 1
Trends in older adult cancer mortality in Switzerland 1991–2008
Kurt Schmidlina, Adrian Spoerria, Matthias Eggera,b, Marcel Zwahlena, Andreas Stuckc, Kerri M. Clough-Gorra,d,e for the Swiss National
Cohort (SNC)
a Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland
b Department of Social Medicine, University of Bristol, United Kingdom
c Division of Geriatrics, Department of General Internal Medicine, Inselspital University Hospital and University of Bern, Switzerland
d National Institute for Cancer Epidemiology and Registration (NICER) Institute of Social and Preventive Medicine (ISPM), University of Zürich, Switzerland
e Section of Geriatrics, Boston University Medical Center, Boston, MA, USA
Summary
PRINCIPLES: It is crucial for aging societies to evaluate
trends in cancer mortality rates of older adults. This study
examined socio-demographic and regional characteristics
specifically focused on the cancer mortality experience of
older adults in Switzerland.
METHODS: This study included all individuals ≥65 years
based on 1990/2000 censuses linked to mortality records to
end of 2008 in the Swiss National Cohort. Gender-age-spe-
cific (<65, 65–74, 75–84, 85+ years) mortality rates were
calculated as observed (cancer deaths/person years) and ex-
pected from Poisson models adjusted for changes in death
record coding over follow-up.
RESULTS: Cancer mortality, except for lung cancer, in-
creased with advancing age. Older men in all age groups
had overall higher cancer mortality rates than older women
and showed a consistent decline in all-cancer mortality
(age 65–74 years 1991 rate ratio (RR) = 1.13 [95%CI 1.08,
1.19]; 2008 RR = 0.88 [95%CI 0.86, 0.90], compared to
rates 2000). In contrast, older women in all age groups
showed early declines with a levelling-off of all-cancer
mortality beginning in 2000 (age 65–74 years 1991 RR =
1.20 [95%CI 1.14, 1.27]; 2008 RR = 0.96 [95%CI 0.93,
0.98], compared to rates 2000). For older men there ap-
peared to be an education effect for all-cancer and lung
cancer mortality; highest rates in older men with compuls-
ory education. Younger old women living alone or in sub-
urban areas had the most sharpest increase in lung cancer
mortality rates.
CONCLUSION: This comprehensive epidemiological ana-
lysis of cancer mortality trends in older adults provides
further evidence that in Switzerland (like other developed
countries) cancer is a disease of aging with important
gender-age-specific variations representing major public
health challenges for aging societies.
Key words: cancer; cancer epidemiology; cancer
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Introduction
Population aging is occurring worldwide but most rapidly
in the developed countries. These societies will need to
pay close attention to how they respond to the associated
challenges and opportunities. Switzerland has one of the
developed world’s most pronounced increases of life ex-
pectancy (women 84.4 years, men 79.8 years in 2009) [1].
Consequently, the population of Swiss older adults (≥65
years) which was nearly 17% in 2009 is projected to in-
crease to 28% by 2050 [1]. For Switzerland and other de-
veloped nations cancer is a particular concern: cancer is a
disease of aging and a leading cause of morbidity and mor-
tality in older people. Cancer incidence and mortality rates
rise steeply in both men and women after age 60 years.
Figure 1
Age-specific cancer mortality from 1991 through 2008 in Swiss men
≥65 years old.
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Similarly to other developed countries, 62% of all-cancer
mortality in Switzerland occurs in persons ≥70 years old;
reflected similarly for most cancer-specific rates [2, 3].
Analysis of mortality trends is an important tool for mon-
itoring the burden of cancer and developing cancer control
programmes. Trends in cancer mortality in Switzerland
(from registration and mortality data) have been published
1980–2001 [4, 5], annually by federal organisations [3] and
included in comprehensive overviews of cancer in Europe
[6–8]. However, cancer mortality trends were examined
without explicit consideration for older age groups (the
most affected persons) or potentially important socio-
demographic factors [3–6, 9].
It is crucial for aging societies to focus careful studies
on cancer mortality trends in older adults because of their
far-reaching implications for the individual, society, and
healthcare policy. To address existing knowledge gaps, we
conducted a comprehensive epidemiologic analysis of
gender-age-specific trends of all-cancer and cancer-specif-
ic mortality for the most common cancers in older Swiss
men and women over the last two decades [10]. Making
use of the Swiss National Cohort (SNC) Study, a census-
based national research platform, we considered socio-
demographic and regional characteristics specifically fo-
cused on the cancer mortality experience of older adults in
Switzerland [11].
Methods
Study population
The SNC based on the 1990 and 2000 national censuses is
described elsewhere [11, 12]. In brief, census records were
linked to federal death or emigration records by probab-
ilistic record linkage using the Generalised Record Link-
age System (GRLS) [13, 14]. Linkage was based on a set
of key variables available in both datasets (e.g. sex, date
of birth, place of residence, marital status, religion, nation-
ality, profession, date of birth of partner, date of birth of
children). Because participation in the Swiss census, resid-
ence registration, and standardised death certificate report-
ing are mandatory, enumeration is virtually complete; the
Web figure 1A
Age-specific all-cancer mortality rates from 1991 through 2008 for
older Swiss men (≥65 years old) by education level.
2000 census estimated coverage as 98.6% [15]. The cur-
rent study population included all individuals recorded in
the 1990 and/or 2000 census linked to mortality records to
Web figure 1B
Age-specific all-cancer mortality rates from 1991 through 2008 for
older Swiss women (≥65 years old) by education level.
Web figure 1C
Age-specific lung cancer mortality rates from 1991 through 2008 for
older Swiss men (≥65 years old) by education level.
Web figure 1D
Age-specific lung cancer mortality rates from 1991 through 2008 for
older Swiss women (≥65 years old) by education level.
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the end of 2008 (N = 8,527,638) providing maximally 18
years of follow-up (1 January 1991 to 31 December 2008).
Because this was a priori analysis of the older Swiss popu-
lation we restricted study entry age to those ≥65 years (N =
2,253,378).
Analytic variables
All cancer and cancer-specific mortality
All-cancer and cancer-specific deaths recorded on official
Swiss death certificates between 1 January 1990 and 31
December 2008 were included in these analyses. Death
certificates have been shown to be an accurate source of
assigning cancer deaths [16, 17]. All-cancer deaths (N =
208,239) were coded as underlying cause of death by In-
ternational Classification of Diseases (ICD) version 8 (be-
fore 1995 codes 140–209) and ICD-10 (after 1995 codes
C00–C97). Cancer-specific deaths included: breast cancer
(N = 16,733) codes 174–175 and C50; colorectal cancer (N
= 24,582) codes 153–154 and C18–C21; lung cancer (N
= 33,454) codes 162 and C33–C34; prostate cancer (N =
22,740) codes 185 and C61.
Socio-demographic and regional characteristics
All socio-demographic and regional characteristics were
measured using variables from the census. Questionnaires
(German, French, Italian, English) and variable lists (Ger-
man, French) are available from the SNC website at
www.swissnationalcohort.ch [12]. Specifically included in
these analyses were: sex; age at census (<65, 65-74, 75-84,
85+ years); nationality (Swiss, non-Swiss); educational at-
tainment (compulsory schooling of up to 9 years’ education
or less; secondary education, tertiary education, not
known); marital status (single, married, widowed, di-
vorced); household type (lives alone, two or more persons,
institution); religion (Catholic, Protestant, no denomina-
tion, other/undeclared); urbanisation (urban, suburban, rur-
al, for additional detail in German/French see
www.bfs.admin.ch/bfs/portal/); language region (German,
French, Italian). For additional regional analyses we also
considered canton and the seven greater geographical re-
gions in Switzerland (Central, Eastern, Zurich, Espace Mit-
telland, Lake Geneva, Northwestern, and Ticino, for addi-
tional detail in German/French see www.bfs.admin.ch/bfs/
portal/).
Analytical strategy
Cancer mortality rates were calculated using person years
(PY) at risk. At risk time began on 1 January 1991 or 5
December 2000 (census date) if ≥65 years at census date,
otherwise on date of 65th birthday. It ended on (first occur-
rence of) date of death, date of emigration from Switzer-
land, 4 December 2000 for persons identified only in 1990
census, or 31 December 2008. At risk time accrued based
on age; so the day someone reached an upper age-group
limit their PY were thereafter assigned to the next older
age group. Total at risk person-time (person years [PY] age
65–74, 75–84, 85+ years respectively) was 4,747,989PY;
2,640,244PY; 715,836PY for men and 5,826,815PY;
4,211,652PY; 1,769,929PY for women. All unlinked death
records were assigned an appropriately chosen (matched
for sex, age within 1 year) census record to avoid underes-
timation of absolute mortality rates [18]. For several cancer
sites, a previously described sharp drop in mortality rates
1994–1995 (most pronounced in cancers with longer sur-
vival and older age groups) was the byproduct of Swiss
Federal Statistical Office coding changes (revised official
cause of death priority policy and switched ICD-8 to
ICD-10) [19]. Consequently, we adjusted mortality rates
before 1995 to compensate for this overestimation by in-
cluding an indicator variable for calendar years after 1994
[18].
Gender-age-specific all-cancer and cancer-specific abso-
lute rates per calendar year 1991–2008 were calculated and
stratified by socio-demographic and regional variables de-
scribed above. Observed rates were calculated as events
(count of all-cancer or cancer-specific deaths) over PY.
Poisson regression models estimated rates over time with
the natural logarithm of the number of events as the out-
come including the natural logarithm of PY as fixed offset
[19]. Restricted cubic splines were included to flexibly
model time trends. Models estimated cancer mortality rates
with 95% confidence intervals (CI). Reported herein ob-
served rates, estimated (EST) rates, and EST rate ratios
(RR) comparing individual yearly rates (e.g. 1991or 2008)
with 2000 yearly rate (approximated mid-follow-up point)
as reference (e.g. RR >1.0 1991/2008 comparison yearly
rate higher than 2000; RR <1.0 1991/2008 comparison
yearly rate lower than 2000) [18]. All analyses were done
using Stata version 11.1 [20].
Results
Due to the comprehensive nature of these analyses (number
of cancer sites and independent variables) we include
herein only the most important results. Additional selected
results are available as web figures online and full results
are available upon request from the authors.
Figure 2
Age-specific cancer mortality from 1991 through 2008 in Swiss
women ≥65 years old.
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Characteristics of the study population
The characteristics of the study population are listed in
table 1. Consistent with older adult populations, more wo-
men than men were included. Approximately one-third
were age 65–74 years at census and nearly 40% turned
65 after census date. The population was overwhelmingly
Swiss (>90%), well educated (majority secondary or ter-
tiary education), married (>60%), and lived in multi-person
households (>65%). The population reflected expected
Swiss language distributions, while only one-quarter lived
in rural communities. The population was similar across
gender, except (characteristically of older populations) men
were younger, more educated, and more often married liv-
ing in multi-person households.
Gender-age-specific trends in older adult cancer
mortality
Gender-age-specific cancer mortality trends of the popula-
tion are shown in figures 1 and 2. Cancer mortality, except
for lung cancer, increased with advancing age. Older men
in all age-groups had overall higher all-cancer and cancer-
specific mortality rates than older women. Older men in
Web figure 2A
Age-specific lung cancer mortality rates from 1991 through 2008 for
older Swiss men (≥65 years old) by household type.
Web figure 2B
Age-specific lung cancer mortality rates from 1991 through 2008 for
older Swiss women (≥65 years old) by household type.
all age groups also showed a consistent decline in all-can-
cer mortality 1991–2008 (fig. 1 Panel A: age 65–74 years
EST 1991 RR = 1.13 [95%CI 1.08, 1.19]; 2008 RR = 0.88
[95%CI 0.86, 0.90]). This was reflected in overall declin-
ing cancer-specific rates in older men.
In contrast, older women in all age-groups showed early
declines with a levelling-off of all-cancer mortality begin-
ning in 2000 (fig. 2 Panel A: age 65–74 years EST 1991
RR = 1.20 [95%CI 1.14, 1.27]; 2008 RR = 0.96 [95%CI
0.93, 0.98]). Increasing lung cancer mortality rates in older
women (fig. 2 Panel D: age 65–74 years EST 1991 RR =
0.65 [95%CI 0.53, 0.79]; 2008 RR = 1.30 [95%CI 1.21,
1.40]) were in part offset by decreases in rates for other
common cancers (e.g. colorectal and breast cancer) across
age-groups over the period.
Socio-demographic trends in older adult cancer
mortality
We analysed all-cancer and cancer-specific mortality rates
from 1991 to 2008 for older men and women by all socio-
demographic variables listed in table 1. For older men there
appeared to be an education effect on trends for all-can-
cer and lung cancer mortality with the highest rates among
older men with compulsory education (web fig. 1A: men
all-cancer age 65–74 years EST 1991 1205/100,000PY
[95%CI 1118, 1299] compulsory, 978/100,000PY [95%CI
913, 1046] secondary, 797/100,000PY [95%CI 703, 904]
tertiary and EST 2008 1016/100,000PY [95%CI 982,
1052] compulsory, 842/100,000PY [95%CI 822, 863] sec-
ondary, 608/100,000PY [95%CI 585, 632] tertiary; web
fig. 1C: men lung cancer age 65–74 years EST 1991 370/
100,000PY [95%CI 318, 430] compulsory, 310/100,000PY
[95%CI 268, 358] secondary, 175/100,000PY [95%CI 129,
236] tertiary and EST 2008 337/100,000PY [95%CI 315,
360] compulsory, 242/100,000PY [95%CI 230, 254] sec-
ondary, 140/100,000PY [95%CI 128, 153]) tertiary). Other
socio-demographic variables showed little effect on mor-
tality rates.
In general, for older women mortality rates remained com-
paratively constant regardless of education level, marital
status, religion, or type of household. Surprisingly,
however, young older women (≤74 years) living in single
person households had the most sharply increasing lung
cancer mortality rates (web fig. 2B: age 65–74 years EST
1991 RR = 0.59 [95%CI 0.44, 0.79], 2008 RR = 1.46
[95%CI 1.31, 1.63] single; 1991 RR = 0.67 [95%CI 0.50,
0.90], 2008 RR = 1.21 [95%CI 1.09, 1.34] multi-person;
1991 RR = 0.99 [95%CI 0.41, 2.40], 2008 RR = 0.78
[95%CI 0.48, 1.27] institution).
Regional trends in older adult cancer mortality
Mortality rates by language region, canton, and greater
regions showed little variation in gender-age-specific all-
cancer or cancer-specific trends over the period. However,
stratification by urbanisation showed older women in sub-
urban and rural areas had the most steeply increasing rates
of lung cancer mortality (web fig. 3B: lung cancer women
age 65–74 years EST 1991 RR = 0.85 [95%CI 0.63, 1.14],
2008 RR = 1.22 [95%CI 1.08, 1.37] urban; 1991 RR = 0.48
[95%CI 0.34, 0.67], 2008 RR = 1.33 [95%CI 1.19, 1.50]
suburban; 1991 RR = 0.53 [95%CI 0.32, 0.88], 2008 RR =
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1.45 [95%CI 1.23, 1.71] rural). Although most often older
urban women had the overall highest rates and 2008 fe-
male lung cancer mortality rates were still well below male
rates. Older men living in suburban areas had the lowest
lung cancer mortality rates.
Discussion
This comprehensive epidemiological analysis of cancer
mortality trends in older adults provides further evidence
that in Switzerland (like other developed countries) cancer
is a disease of aging. But it also elucidates gender-age-
specific cancer mortality variation in older age-groups by
socio-demographic and regional factors. Overall, trends in
cancer mortality were higher in men than women, in-
creased by age, and except for lung cancer decreased over
the past two decades. Of particular interest were findings
of attenuated male cancer mortality rates by educational
attainment and pronounced lung cancer mortality rates in
younger older women living alone and/or in non-urban set-
tings.
Although cancer mortality rates declined in older women
there was a distinct levelling-off of the decline after 2000
Web figure 3A
Age-specific lung cancer mortality rates from 1991 through 2008 for
older Swiss men (≥65 years old) by urbanisation of community of
residence.
Table 1: Characteristics of the analytical study population (older Swiss adults ≥65 years old), 1991–2008.
Males Females
Total 986,634 (43.8%) 1,266,744 (56.2%)
Age at 1990 census
<65 years §
65–74 years
75–84 years
85+ years
300,592 (30.5%)
231,609 (23.5%)
130,688 (13.2%)
28,774 (2.9%)
345,094 (27.2%)
296,476 (23.4%)
221,246 (17.5%)
74,971 (5.9%)
Age at 2000 census
<65 years §
65–74 years
75–84 years
85+ years
281,521 (28.5%)
263,056 (26.7%)
146,993 (14.9%)
41,109 (4.2%)
302,211 (23.9%)
324,726 (25.6%)
234,578 (18.5%)
103,008 (8.1%)
Nationality
Swiss
Non-Swiss
869,840 (88.2%)
116,794 (11.8%)
1,169,358 (92.3%)
97,386 (7.7%)
Educational attainment
Compulsory schooling or less
Secondary education
Tertiary education
Not known
272,837 (27.7%)
483,990 (49.0%)
211,761 (21.5%)
18,046 (1.8%)
662,961 (52.3%)
501,777 (39.6%)
69,617 (5.5%)
32,389 (2.6%)
Marital status
Single
Married
Widowed
Divorced
76,507 (7.8%)
778,765 (78.9%)
73,345 (7.4%)
58,017 (5.9%)
136,867 (10.8%)
675,448 (53.3%)
361,231 (28.5%)
93,198 (7.4%)
Household type
Single person
Multi-person
Institution
135,712 (13.8%)
818,364 (82.9%)
32,558 (3.3%)
396,031 (31.3%)
790,671 (62.4%)
80,042 (6.3%)
Religion
Protestant
Roman Catholic
No denomination
Other / unknown
456,793 (46.3%)
412,358 (41.8%)
79,404 (8.0%)
38,079 (3.9%)
617,559 (48.8%)
539,006 (42.5%)
66,342 (5.2%)
43,837 (3.5%)
Language region
German
French
Italian
712,950 (72.3%)
226,029 (22.9%)
47,655 (4.8%)
907,334 (71.6%)
294,272 (23.2%)
65,138 (5.2%)
Urbanisation
Urban
Surburban
Rural
305,133 (30.9%)
419,611 (42.5%)
261,890 (26.6%)
443,788 (35.0%)
509,519 (40.2%)
313,437 (24.8%)
§ Study entry after census date on 65th birthday.
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(earlier sharper declines similar within European Union)
[21]. The lack of appreciable decline for nearly 10 years
suggests that older women in Switzerland may receive less
benefit from cancer screening and improvements in treat-
ments than older men and younger adults. Findings may
also be influenced by gender-specific changes in smoking
patterns. By international comparison population-based
data from other European countries (e.g. Austria, France,
Germany) and the United States show decreases in all-can-
cer mortality for older women within similar periods [22,
23]. A recent study from Japan also showed mortality rates
declining in both older men and women over the past 10
years [24]. The potential healthcare inequalities underly-
ing these minimal improvements in cancer mortality rates
for older Swiss women should be further evaluated. They
are perhaps an important indicator of a major public health
challenge arising from an increasing cancer burden with in-
adequate prevention and treatment in the growing number
of older women.
Societal effects of smoking are reflected in these gender-
age-specific lung cancer mortality trends. Reported trends
correlate with smoking prevalence (considered the most
important lung cancer risk factor) which are reported as
declining and/or levelling-off in European men over the
past five decades, while simultaneously trending upward
in women until only much more recently [7, 25–27]. Pre-
vious studies of smoking prevalence and lung cancer in
Switzerland indicate that from 1980–1984 approximately
90% of lung cancer deaths in men and 40% in women
could be attributed to smoking (overall proportion 85%)
[28]. Given the long latency period of lung cancer and the
lag in smoking prevalence in Swiss women (women were
not allowed to smoke in Switzerland before 1918) the in-
creasing lung cancer mortality trends were as expected and
similar to other reports for European women [29–31]. But
what is interesting and, to the best of the authors’ know-
ledge as yet unnoted, is that these effects are seemingly
restricted to younger old women living alone and/or in
non-urban areas. These effects were seen even though no
colinearity between the variables existed. Also important
is that the highest lung cancer mortality rates were seen in
Web figure 3B
Age-specific lung cancer mortality rates from 1991 through 2008 for
older Swiss women (≥65 years old) by urbanisation of community of
residence.
older men with lower educational attainment. These spe-
cific variations present a unique public health opportunity
for targeting tobacco cessation programmes (shown to im-
prove prognosis in older adults) and heightened awareness
of lung cancer monitoring in preventing the later stage dia-
gnosis common in older adults [32–34]. For further discus-
sion of educational effects see our companion paper [35].
In particular, the observed regionally similar reduction in
breast cancer mortality before the year 2000 in all age
groups of older Swiss women is noteworthy. Previous pub-
lications on breast cancer mortality and survival in Switzer-
land have shown regional (by language) differences, as
does our companion paper examining relative risks
[35–37]. Further, Ess et al. found considerable geograph-
ical variation in early detection and breast cancer care in
Switzerland, although the findings did not explore older-
age specific differences [38]. Others have proposed that
differences are related to mammography screening pro-
grammes that are generally operational in French-speaking
areas of Switzerland, only beginning in Eastern Switzer-
land, and opportunistic in other regions, may be influential.
But if one considers the pattern of trends reported herein
it is plausible that improvement in treatment before 2000
(e.g. widespread use of hormonal therapy) could have been
the primary reason for the earlier declines in breast cancer
mortality. If treatment changes were more consistently in-
troduced across Switzerland and in older age groups (un-
like mammography) they would explain why trends in ab-
solute rates were level from 2000 onward despite increased
mammography in French-speaking areas. However, if dif-
ferences in breast cancer mortality in women are in fact
related to mammography screening (supporting evidence
mixed), then older Swiss women are not being screened
(despite age-specific supporting evidence) and represent a
sizable, growing, targetable at risk population and public
health opportunity [39–46]. Additional research is needed
and caution is warranted in comparing results across stud-
ies. Previous studies used data from only a subset of re-
gional cancer registries (≤47% of population) and several
cited papers were age truncated (restricted younger age-
group).
Several strengths and weaknesses of this study are to be
considered. First, it included a very large representative
sample of older Swiss adults, allowing it to be generalised
to the older population in Switzerland with statistical preci-
sion. In addition, it is one of the few investigations of can-
cer mortality trends that is specific to older adults, includes
exact PY with a long follow-up, and explores gender-age-
specific variations across a broad set of socio-demographic
and regional characteristics. On the other hand, our age-
group categories, although commonplace, created smaller
distributions in the oldest old (85+ years) group leading
to less stability of stratified results than in younger old
age-groups. Additionally, our study population was based
on probabilistic linkage and therefore subject to associated
limitations [47]. Although previous evaluations of the SNC
have shown no indication of selection bias and that linkage
is least successful primarily in younger adults (a highly mo-
bile group) that by design were excluded from these ana-
lyses [12]. It should also be mentioned that unfortunately
our nearly complete Swiss mortality data did not include
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disease information (i.e. stage by age at diagnosis, treat-
ment characteristics, etc.), health, lifestyle, and/or fully
comprehensive socio-demographic characteristics. Addi-
tional analyses are planned to include cancer incidence as
well as detailed lifestyle and health behaviour data linked
to a representative subset of the current population. These
future analyses will greatly expand our current findings.
In conclusion and despite the lack of more detailed inform-
ation, our findings underscore that cancer mortality in older
adults represents a major public health challenge where
trends seemingly vary less regionally in older populations
than previously suggested in all-age analyses [3, 48]. This
first Swiss older age-specific evidence on cancer mortality
trends can help inform public health decision-making in the
fight against cancer. With older adults becoming an ever-
increasing proportion of the population, Switzerland like
other developed countries, will need to accommodate in-
evitable increases in cancer-related healthcare expenditures
and focus on effective preventive and curative treatment
for them. Efforts should be informed by continually up-
dated age-specific epidemiologic investigations aimed to-
wards reducing the physical and psychological burden of
cancer, knowing that cancer is a disease of aging.
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Figure 1
Age-specific cancer mortality from 1991 through 2008 in Swiss men ≥65 years old.
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Web Figure 1A
Age-specific all-cancer mortality rates from 1991 through 2008 for older Swiss men (≥65 years old) by education level.
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Web Figure 1B
Age-specific all-cancer mortality rates from 1991 through 2008 for older Swiss women (≥65 years old) by education level.
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Web Figure 1C
Age-specific lung cancer mortality rates from 1991 through 2008 for older Swiss men (≥65 years old) by education level.
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Web Figure 1D
Age-specific lung cancer mortality rates from 1991 through 2008 for older Swiss women (≥65 years old) by education level.
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Figure 2
Age-specific cancer mortality from 1991 through 2008 in Swiss women ≥65 years old.
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Web Figure 2A
Age-specific lung cancer mortality rates from 1991 through 2008 for older Swiss men (≥65 years old) by household type.
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Web Figure 2B
Age-specific lung cancer mortality rates from 1991 through 2008 for older Swiss women (≥65 years old) by household type.
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Web Figure 3A
Age-specific lung cancer mortality rates from 1991 through 2008 for older Swiss men (≥65 years old) by urbanisation of community of residence.
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Web Figure 3B
Age-specific lung cancer mortality rates from 1991 through 2008 for older Swiss women (≥65 years old) by urbanisation of community of
residence.
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